Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial metal-dependent pathways are a broad set of essential biological processes that utilize transition metals—primarily iron, zinc, manganese, and copper—as critical cofactors for enzyme catalysis, protein structure, and gene regulation (Chandrangsu et al., 2017). These pathways are vital for bacterial survival and virulence, encompassing metal acquisition systems like siderophores, regulatory proteins such as the Ferric Uptake Regulator (Fur), and numerous metalloenzymes (Bush and Bradford, 2016). Key therapeutic targets within these pathways include LpxC, a zinc-dependent enzyme essential for Gram-negative lipid A biosynthesis, and peptide deformylase (PDF), which is required for protein maturation (Clements et al., 2002; Giglione et al., 2000). Additionally, metallo-beta-lactamases (MBLs) utilize zinc to degrade a wide range of beta-lactam antibiotics, making them major drivers of multi-drug resistance (Bush and Bradford, 2016). Drugs targeting these pathways include direct enzyme inhibitors, such as PDF and LpxC inhibitors, and siderophore-drug conjugates like cefiderocol, which exploit iron transport systems to bypass the bacterial outer membrane (Zhanel et al., 2019). Despite their potential, drug development faces challenges such as achieving selectivity to avoid inhibiting human metalloenzymes and addressing the bacteria's ability to adapt through redundant metal-scavenging mechanisms.
Inhibition of essential bacterial metalloenzymes (e.g., LpxC, PDF), inhibition of metallo-beta-lactamases to restore antibiotic activity, and exploitation of metal transport systems for targeted drug delivery (siderophore-drug conjugates).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial metal-dependent pathways.